Eric Aguiar, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 6,729 shares at $52.20 ($351K) on 2019-11-20, disclosed to the SEC on 2019-11-22.
Open-market sale of $351k BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVTA | SELL | 2020-07-16 | $680K | — | Filing → |
| BHVN | SELL | 2020-01-24 | $114K | — | Filing → |
| BHVN | SELL | 2020-01-10 | $1.7M | — | Filing → |